In this model, the higher concentration of transferrin observed among PSP-RS patients could be explained by compensatory failure or a different mechanism underlying the neurodegenerative process, which is less dependent on microglial activity. This evidence concerns the gene TF and supranuclear palsy, progressive, 1.